# Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma

> **NCT01898403** · NA · COMPLETED · sponsor: **Stanford University** · enrollment: 50 (actual)

## Conditions studied

- Recurrent Melanoma

## Interventions

- **DRUG:** Indocyanine green solution
- **DRUG:** Isosulfan blue (ISB)
- **DIAGNOSTIC_TEST:** Lymphoscintigraphy with 99-technetium (99Tc) sulfur colloid (TSC)

## Key facts

- **NCT ID:** NCT01898403
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-06
- **Final completion:** 2015-04
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-05-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01898403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01898403, "Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01898403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*